Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the American Society of Hematology (ASH) Annual Meeting, Dec. 7-10 in San ...
One in nine New Zealand women get breast cancer in their lifetimes, and around 16% of metastatic breast cancers are ...
The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...
Normally used to identify chromosomal abnormalities, the test could help detect cancer in people who otherwise have no reason ...
A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...
Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...
Barbara O’Brien, MD, discusses the next steps of the phase 2 TBCRC049 study for the treatment of patients with HER2-positive ...
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ ...
Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...